Nu Skin Secures New Five-Year Credit Facilities Agreement

Nu Skin ( (NUS) ) just unveiled an update.

On March 27, 2026, Nu Skin Enterprises, Inc. entered into a Second Amended and Restated Credit Agreement that replaces its June 14, 2022 facility, securing a $175 million five-year term loan and a $75 million five-year revolving credit facility. The term loan was fully drawn at closing and used to repay all amounts outstanding under the prior agreement, while the new senior secured facilities may be used for working capital, capital expenditures, and general corporate purposes, and are backed by guarantees and liens on material subsidiaries, with detailed financial covenants and default provisions that tighten leverage, interest coverage, and capital allocation flexibility for the company.

The most recent analyst rating on (NUS) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Nu Skin stock, see the NUS Stock Forecast page.

Spark’s Take on NUS Stock

According to Spark, TipRanks’ AI Analyst, NUS is a Neutral.

The score reflects mixed fundamentals (profitability rebound and improved balance sheet offset by multi-year revenue decline and only moderate cash conversion) and notably weak technicals. Very low valuation and a solid dividend support the score, while cautious 2026 guidance and execution risk around Prism IO/India cap upside near-term.

To see Spark’s full report on NUS stock, click here.

More about Nu Skin

Nu Skin Enterprises, Inc. operates in the beauty and wellness sector, marketing personal care products and nutritional supplements. The company focuses on global direct selling through a network of independent distributors, positioning itself as a premium skincare and wellness brand in multiple international markets.

Average Trading Volume: 543,272

Technical Sentiment Signal: Sell

Current Market Cap: $349.4M

See more insights into NUS stock on TipRanks’ Stock Analysis page.